Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression.

Chiefari E, Ventura V, Capula C, Randazzo G, Scorcia V, Fedele M, Arcidiacono B, Nevolo MT, Bilotta FL, Vitiello M, Palmieri C, Gulletta E, Fusco A, Foti D, Vero R, Brunetti A.

Sci Rep. 2016 Dec 19;6:39429. doi: 10.1038/srep39429.

2.

Cooperation between HMGA1 and HIF-1 Contributes to Hypoxia-Induced VEGF and Visfatin Gene Expression in 3T3-L1 Adipocytes.

Messineo S, Laria AE, Arcidiacono B, Chiefari E, Luque Huertas RM, Foti DP, Brunetti A.

Front Endocrinol (Lausanne). 2016 Jun 27;7:73. doi: 10.3389/fendo.2016.00073. eCollection 2016.

3.

The Association between HMGA1 rs146052672 Variant and Type 2 Diabetes: A Transethnic Meta-Analysis.

Bianco A, Chiefari E, Nobile CG, Foti D, Pavia M, Brunetti A.

PLoS One. 2015 Aug 21;10(8):e0136077. doi: 10.1371/journal.pone.0136077. eCollection 2015.

4.

A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin.

Arnoldo L, Sgarra R, Chiefari E, Iiritano S, Arcidiacono B, Pegoraro S, Pellarin I, Brunetti A, Manfioletti G.

Sci Rep. 2015 Feb 25;5:8552. doi: 10.1038/srep08552.

5.

Cooperation between HMGA1, PDX-1, and MafA is Essential for Glucose-Induced Insulin Transcription in Pancreatic Beta Cells.

Arcidiacono B, Iiritano S, Chiefari E, Brunetti FS, Gu G, Foti DP, Brunetti A.

Front Endocrinol (Lausanne). 2015 Jan 13;5:237. doi: 10.3389/fendo.2014.00237. eCollection 2014.

6.

Recent advances in the molecular genetics of type 2 diabetes mellitus.

Brunetti A, Chiefari E, Foti D.

World J Diabetes. 2014 Apr 15;5(2):128-40. doi: 10.4239/wjd.v5.i2.128. Review.

7.

Early effects of a hypocaloric, Mediterranean diet on laboratory parameters in obese individuals.

Greco M, Chiefari E, Montalcini T, Accattato F, Costanzo FS, Pujia A, Foti D, Brunetti A, Gulletta E.

Mediators Inflamm. 2014;2014:750860. doi: 10.1155/2014/750860. Epub 2014 Mar 4.

8.

Transcriptional regulation of the HMGA1 gene by octamer-binding proteins Oct-1 and Oct-2.

Chiefari E, Arcidiacono B, Possidente K, Iiritano S, Ventura V, Pandolfo R, Brunetti FS, Greco M, Foti D, Brunetti A.

PLoS One. 2013 Dec 18;8(12):e83969. doi: 10.1371/journal.pone.0083969. eCollection 2013.

9.

Gestational diabetes mellitus: screening and outcomes in southern italian pregnant women.

Capula C, Chiefari E, Vero A, Arcidiacono B, Iiritano S, Puccio L, Pullano V, Foti DP, Brunetti A, Vero R.

ISRN Endocrinol. 2013 Sep 5;2013:387495. doi: 10.1155/2013/387495. eCollection 2013.

10.

Predictors of postpartum glucose tolerance testing in italian women with gestational diabetes mellitus.

Capula C, Chiefari E, Vero A, Iiritano S, Arcidiacono B, Puccio L, Pullano V, Foti D, Brunetti A, Vero R.

ISRN Endocrinol. 2013 Jul 17;2013:182505. doi: 10.1155/2013/182505. eCollection 2013.

11.

A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components.

Chiefari E, Tanyolaç S, Iiritano S, Sciacqua A, Capula C, Arcidiacono B, Nocera A, Possidente K, Baudi F, Ventura V, Brunetti G, Brunetti FS, Vero R, Maio R, Greco M, Pavia M, Hodoglugil U, Durlach V, Pullinger CR, Goldfine ID, Perticone F, Foti D, Brunetti A.

Sci Rep. 2013;3:1491. doi: 10.1038/srep01491.

12.

Functional relationship between high mobility group A1 (HMGA1) protein and insulin-like growth factor-binding protein 3 (IGFBP-3) in human chondrocytes.

Gasparini G, De Gori M, Paonessa F, Chiefari E, Brunetti A, Galasso O.

Arthritis Res Ther. 2012 Oct 4;14(5):R207. doi: 10.1186/ar4045.

13.

The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake.

Iiritano S, Chiefari E, Ventura V, Arcidiacono B, Possidente K, Nocera A, Nevolo MT, Fedele M, Greco A, Greco M, Brunetti G, Fusco A, Foti D, Brunetti A.

Mol Endocrinol. 2012 Sep;26(9):1578-89. doi: 10.1210/me.2011-1379. Epub 2012 Jun 28.

14.

Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms.

Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, Foti D, Chiefari E, Brunetti A.

Exp Diabetes Res. 2012;2012:789174. doi: 10.1155/2012/789174. Epub 2012 Jun 4. Review.

15.

Comment on: Marquez et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 2012;61:524-530.

Brunetti A, Chiefari E, Pullinger CR, Tanyolac S, Foti D, Durlach V, Goldfine ID.

Diabetes. 2012 May;61(5):e3. doi: 10.2337/db12-0051. No abstract available.

16.

HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway.

Chiefari E, Nevolo MT, Arcidiacono B, Maurizio E, Nocera A, Iiritano S, Sgarra R, Possidente K, Palmieri C, Paonessa F, Brunetti G, Manfioletti G, Foti D, Brunetti A.

Sci Rep. 2012;2:251. doi: 10.1038/srep00251. Epub 2012 Feb 7.

17.

New target genes for the peroxisome proliferator-activated receptor-γ (PPARγ) antitumour activity: Perspectives from the insulin receptor.

Foti DP, Paonessa F, Chiefari E, Brunetti A.

PPAR Res. 2009;2009:571365. doi: 10.1155/2009/571365. Epub 2009 Jun 29.

18.

The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis.

Chiefari E, Paonessa F, Iiritano S, Le Pera I, Palmieri D, Brunetti G, Lupo A, Colantuoni V, Foti D, Gulletta E, De Sarro G, Fusco A, Brunetti A.

BMC Biol. 2009 May 21;7:24. doi: 10.1186/1741-7007-7-24.

19.

Transcriptional activity of the murine retinol-binding protein gene is regulated by a multiprotein complex containing HMGA1, p54 nrb/NonO, protein-associated splicing factor (PSF) and steroidogenic factor 1 (SF1)/liver receptor homologue 1 (LRH-1).

Bianconcini A, Lupo A, Capone S, Quadro L, Monti M, Zurlo D, Fucci A, Sabatino L, Brunetti A, Chiefari E, Gottesman ME, Blaner WS, Colantuoni V.

Int J Biochem Cell Biol. 2009 Nov;41(11):2189-203. doi: 10.1016/j.biocel.2009.04.011. Epub 2009 Apr 21.

20.

Supplemental Content

Loading ...
Support Center